Australia Opioid Use Disorder Market Size & Outlook

The opioid use disorder market in Australia is expected to reach a projected revenue of US$ 131.9 million by 2030. A compound annual growth rate of 10.7% is expected of Australia opioid use disorder market from 2025 to 2030.
Revenue, 2024 (US$M)
$71.8
Forecast, 2030 (US$M)
$131.9
CAGR, 2025 - 2030
10.7%
Report Coverage
Australia

Australia opioid use disorder market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia opioid use disorder market, 2018-2030 (US$M)

Australia opioid use disorder market highlights

  • The Australia opioid use disorder market generated a revenue of USD 71.8 million in 2024 and is expected to reach USD 131.9 million by 2030.
  • The Australia market is expected to grow at a CAGR of 10.7% from 2025 to 2030.
  • In terms of segment, buprenorphine was the largest revenue generating drug in 2024.
  • Buprenorphine is the most lucrative drug segment registering the fastest growth during the forecast period.


Opioid use disorder market data book summary

Market revenue in 2024USD 71.8 million
Market revenue in 2030USD 131.9 million
Growth rate10.7% (CAGR from 2025 to 2030)
Largest segmentBuprenorphine
Fastest growing segmentBuprenorphine
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBuprenorphine, Methadone, Naltrexone
Key market players worldwideIndivior PLC Ordinary Share, Alkermes PLC, Titan Pharmaceuticals Inc, Hikma Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd, MediciNova Inc, Orexo AB, Camurus AB, Omeros Corp


Other key industry trends

  • In terms of revenue, Australia accounted for 1.4% of the global opioid use disorder market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, India opioid use disorder market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 304.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Opioid Use Disorder Market Companies

Name Profile # Employees HQ Website

Australia opioid use disorder market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to opioid use disorder market will help companies and investors design strategic landscapes.


Buprenorphine was the largest segment with a revenue share of 59.61% in 2024. Horizon Databook has segmented the Australia opioid use disorder market based on buprenorphine, methadone, naltrexone covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Australia opioid use disorder market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia opioid use disorder market databook

  • Our clientele includes a mix of opioid use disorder market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia opioid use disorder market , including forecasts for subscribers. This country databook contains high-level insights into Australia opioid use disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia opioid use disorder market size, by drug, 2018-2030 (US$M)

Australia Opioid Use Disorder Market Outlook Share, 2024 & 2030 (US$M)

Australia opioid use disorder market size, by drug, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more